跳至主要内容
临床试验/NL-OMON42622
NL-OMON42622已完成2 期

ociceptive-Level (NoL)-guided analgesia versus standard practice during general remifentanil/propofol anesthesia in ASA 1-3 patients - NoLA

eids Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age: 18-80 years;
  • 2. ASA I-II-III
  • 3. Elective open abdominal surgery or laparoscopic assisted abdominal surgery.

排除标准

  • 1. Unable to give written informed consent;
  • 2. Use of epidural analgesia or local anesthesia (eg. transversus abdominal plain block, TAP block)
  • 3. Non-elective surgery
  • 4. Pregnancy/lactation;
  • 5. BMI > 35 kg/m2;
  • 6. Uncontrolled preoperative hypo- or hypertension (Mean arterial pressure < 60 mmHg or > 100 mmHg)
  • 7. Preoperative Heart rate < 45/min or > 90/min;
  • 8. Central nervous system disorder (neurologic/head trauma/uncontrolled epileptic seizures);
  • 9. Illicit substance or alcohol abuse within 30 days;
  • 10. Chronic use of pain medication within 30 days;
  • 11. Chronic use of psychoactive drugs within 30 days;
  • 12. Significant medical condition
  • a. Untreated or persistent peripheral or central cardiovascular disease
  • b. Severe pulmonary disease e.g. COPD gold 4 , FEV< 1.0 L/s, or (evidence of) elevated paCO2 > 6.0 kPa
  • c. Significant hepatic disease with increased bilirubin, INR or low albumin
  • 13. Beta blocker use

研究者

相似试验

ociceptive-Level (NoL)-guided analgesia versus... | 临床试验